Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ViiV Healthcare

Division of GlaxoSmithKline PLC
www.viivhealthcare.com

Latest From ViiV Healthcare

Longer Intervals OK With ViiV's Injectable Anti-HIV Regimen

Topline results from the Phase III ATLAS-2M study indicate that injections every two months of ViiV/Janssen’s two-drug anti-HIV regimen are non-inferior to a once-monthly injectable regimen.

 

Infectious Diseases Clinical Trials

Janssen And ViiV: Giving HIV/AIDS Patients Options Is Key

With EU submissions for once-monthly long-acting  anti-HIV antivirals in hand, Janssen and ViiV appear to have set their sights on providing patients with more options.

Infectious Diseases Research and Development Strategies

Merck Positions MK-8591 As Backbone For HIV Treatment And Prophylaxis

First-in-class antiviral could be a potential backbone for combo regimens and entry into PrEP. New data releases at IAS highlight potential in both settings.

Clinical Trials Infectious Diseases

ViiV Says Latest Data Back Two-Drug Approach, Plans Year-End Fostemsavir Filing

ViiV Healthcare research head tells Scrip she expects Dovato’s latest data presentation should boost the two-drug regimen’s uptake, and that the AIDS-fighter plans a US FDA filing of its investigational candidate fostemsavir before end-2019 following good Phase III BRIGHTE results.

Commercial Research & Development
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • GSK Pfizer HIV
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Jerome Andries, CFO
    John Pottage, MD, CSO & CMO
    Gregory Reinaud, Head, Global Commercial Strategy
  • Contact Info
  • ViiV Healthcare
    Phone: (44) (0)20 8380 6200
    980 Great West Rd.
    Brentford, TW8 9GS
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register